Human Microbiome Strategic Business Research Report 2024: Global Market to Reach $2.8 Billion by 2030 from $486 Million in 2023, Driven by Dow, DuPont de Nemours, and Enterome Among Others
Portfolio Pulse from
The global human microbiome market is projected to grow from $486 million in 2023 to $2.8 billion by 2030, driven by companies like Dow, DuPont de Nemours, and Enterome. The Gastrointestinal Diseases segment is expected to reach $1.3 billion by 2030 with a CAGR of 28.7%, while the Endocrine & Metabolic Disorders segment will grow at a 23.6% CAGR. The U.S. market was valued at $141.2 million in 2023, and China's market is forecasted to grow at a 27.4% CAGR to $417.6 million by 2030.
December 03, 2024 | 4:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
DuPont de Nemours is a key player in the rapidly growing human microbiome market, expected to reach $2.8 billion by 2030. The company's involvement in this market could drive significant revenue growth.
DuPont de Nemours is highlighted as a key driver in the human microbiome market, which is expected to grow significantly. This positions the company for potential revenue increases.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80